©The Author(s) 2016.
World J Hepatol. Dec 18, 2016; 8(35): 1584-1592
Published online Dec 18, 2016. doi: 10.4254/wjh.v8.i35.1584
Published online Dec 18, 2016. doi: 10.4254/wjh.v8.i35.1584
Table 2 Newcastle - Ottawa Scale on quality score of the included studies
| Ref. | Selection | Comparability | Exposure | Total | |||||
| Independent validation | Case representation | Controls selection | Controls definition | Case and control design/analysis | Ascertainment of exposure | Same method of ascertainment | Same response rate | ||
| Cai et al[39] (2011) | 1 | 1 | 2 | 1 | 1 | 1 | 7 | ||
| Valenti et al[40] (2011) | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 9 |
| Trépo et al[41] (2011) | 1 | 1 | 2 | 1 | 5 | ||||
| Corradini et al[42] (2011) | 1 | 1 | 2 | 1 | 5 | ||||
| Nischalke et al[13] (2011) | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 9 |
| Valenti et al[43] (2012) | 1 | 1 | 2 | 1 | 1 | 6 | |||
| Valenti et al[15] (2012) | 1 | 1 | 2 | 1 | 1 | 6 | |||
| Guyot et al[12] (2013) | 1 | 1 | 2 | 1 | 5 | ||||
| Ezzikouri et al[44] (2013) | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 9 |
| Stättermayer et al[45] (2014) | 1 | 1 | 2 | 1 | 5 | ||||
| Ampuero et al[46] (2014) | 1 | 1 | 2 | 1 | 1 | 1 | 7 | ||
| Sato et al[47] (2014) | 1 | 1 | 2 | 1 | 5 | ||||
| Yasui et al[48] (2014) | 1 | 1 | 2 | 1 | 5 | ||||
| Petta et al[14] (2015) | 1 | 1 | 2 | 1 | 5 | ||||
| Nakaoka et al[49] (2015 ) | 1 | 1 | 2 | 1 | 5 | ||||
| Tamaki et al[50] (2015) | 1 | 1 | 2 | 1 | 1 | 1 | 7 | ||
| Huang et al[51] (2015) | 1 | 1 | 2 | 1 | 1 | 1 | 7 | ||
| Petta et al[52] (2016) | 1 | 1 | 2 | 1 | 1 | 1 | 7 | ||
| Ali et al[53] (2016) | 1 | 1 | 2 | 1 | 1 | 1 | 7 | ||
- Citation: Salameh H, Masadeh M, Al Hanayneh M, Petros V, Maslonka M, Nanda A, Singal AK. PNPLA3 polymorphism increases risk for and severity of chronic hepatitis C liver disease. World J Hepatol 2016; 8(35): 1584-1592
- URL: https://www.wjgnet.com/1948-5182/full/v8/i35/1584.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i35.1584